GENUS ONCOLOGY

genus-oncology-logo

Genus Oncology was formed in 2007 with a mission of discovering, developing, and commercializing new anti-cancer agents that target the Mucin 1 (MUC1) oncoprotein. The incidence of overexpressed MUC1 in a wide array of carcinomas and hematologic malignancies has been known by researchers for many years. Until now, no viable approach existed to selectively target and block the function of MUC1 that leads to the formation of tumors.

#SimilarOrganizations #People #Financial #Website #More

GENUS ONCOLOGY

Industry:
Biotechnology Health Care

Founded:
2007-01-01

Address:
Vernon Hills, Illinois, United States

Country:
United States

Website Url:
http://www.genusoncology.com

Total Employee:
1+

Status:
Active

Contact:
8475496500

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Google Apps For Business Namecheap DNS Weebly Hosting Network Solutions Email Hosting


Similar Organizations

aviaradx-logo

AviaraDx

AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.


Current Advisors List

rick-kash_image

Rick Kash Chairman @ Genus Oncology
Board_member

Current Employees Featured

not_available_image

Surender Kharbanda
Surender Kharbanda Founder & CSO @ Genus Oncology
Founder & CSO
2008-01-01

Founder


not_available_image

Surender Kharbanda

Investors List

lightbank_image

Lightbank

Lightbank investment in Series A - Genus Oncology

Official Site Inspections

http://www.genusoncology.com

  • Host name: 104.21.25.65
  • IP address: 104.21.25.65
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Genus Oncology"

Genus Oncology - Crunchbase Company Profile

Genus Oncology was formed in 2007 with a mission of discovering, developing, and commercializing new anti-cancer agents that target the Mucin 1 (MUC1) …See details»

About Us - GENUS ONCOLOGY - THE MUC1-C COMPANY

Genus Oncology is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the treatment of patients …See details»

Genus Oncology 2025 Company Profile: Valuation, …

Genus Oncology General Information Description. Developer of peptide-and antibody-based drugs designed to treat cancer. The company's focus is in discovering and developing first-in-class agents against the MUC1-C …See details»

GENUS ONCOLOGY, LLC - VentureRadar

"Genus Oncology is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the treatment of patients …See details»

Genus Oncology LLC Information - RocketReach

What is the annual revenue of Genus Oncology LLC? The Genus Oncology LLC annual revenue was $811000 in 2024.See details»

About - Lenus Oncology

Affordability is a key priority at Lenus Oncology. Recognizing the financial burden that cancer treatment can impose, the center strives to offer competitive pricing and financial assistance …See details»

Genus Oncology Headquarters and Office Locations - Craft

Genus Oncology is headquartered in Boston, 650 Albany St, United States, and has 2 office locations.See details»

Contact - Lenus Oncology

Registered Office: C-35 B, Chander Nagar, Ghaziabad, Uttar Pradesh, PIN code: 201011See details»

Genus Oncology - Overview, News & Similar companies - ZoomInfo

Who is Genus Oncology. Genus has maintained a unique and leading position in the MUC1 field, driven by recent discoveries made at Dana-Farber Cancer Institute (DFCI), Har vard Medical …See details»

Team – Lenus Oncology

Email - [email protected]. Home; About; Cancer Centres; Services; Blog; Contact; Menu. Login . Team. Home Team. We aim to make quality cancer care accessible to people all over …See details»

Genus Oncology LLC - Company Profile and News - Bloomberg …

Company profile page for Genus Oncology LLC including stock price, company news, executives, board members, and contact informationSee details»

GENUS ONCOLOGY - THE MUC1-C COMPANY - Company

Genus Oncology, The MUC1-C Company, is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the …See details»

Cancer Centres – Lenus Oncology

© 2023 Lenus Oncology. All rights reserved. XSee details»

Breast Cancer – Lenus Oncology

Email - [email protected]. Home; About; Cancer Centres; Services; Blog; Contact; Menu. Login . Breast Cancer. Home Breast Cancer. Overview. Breast cancer is a type of cancer that …See details»

Chronic Myeloid Leukemia – Lenus Oncology

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that affects the blood and bone marrow. It is characterized by the overproduction of …See details»

General Oncology: A Pharmaceutical Company

General Oncology is a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers.See details»

Treatments & Services – Lenus Oncology

Our state-of-the-art radiotherapy facilities employ advanced technologies to deliver precise radiation treatment to cancerous tumors. Our radiation oncologists and therapists work closely …See details»

The end of the genetic paradigm of cancer | PLOS Biology

Mar 18, 2025 Cancer as a tissue-based disease: The tissue organization field theory of carcinogenesis. The interpretation of genome sequence-based lineage reconstruction (Table …See details»

Next-Generation Sequencing in Oncology—A Guiding Compass …

23 hours ago Multigene sequencing technologies provide a foundation for targeted therapy and precision oncology by identifying actionable alterations and enabling the development of …See details»

Glioblastoma – Lenus Oncology

Glioblastoma, also known as glioblastoma multiforme (GBM), is a highly aggressive and malignant brain tumor that arises from glial cells in the central nervous system.See details»

linkstock.net © 2022. All rights reserved